Open access · CC-BY
via OpenAlex
Inflammaging and osteoarthritis - therapeutic opportunities
Megan Chan, Phoebe Low, Shi Chee Ong, Sze Mun Choy, Wen Xing Lee, Kah Yong Goh, Kym Ng, Kimberly Chua, Jia Ying Lee, Alvin Kunyao Guo, Jiang Jia, Eng King Tan, Hong-Wen Tang, Kenon Chua
Frontiers in Immunology · 2026 · ▲ 4 citations
Deregulated nutrient-sensing
Cellular senescence
Altered intercellular communication
Chronic inflammation
Gene therapy
Rapamycin / mTOR inhibition
Metformin
Human
Review
Abstract
As patients age, cellular senescence(definition) results in senescence-associated secretory phenotype (SASP). The SASP results in secretion of pro-inflammatory cytokines, chemokines, and proteases that drive chronic inflammation and cartilage degradation in osteoarthritis (OA). Accumulation of senescent chondrocytes and macrophages activates key signaling pathways such as NF-κB, MAPK/p38, mTOR(definition), AMPK, and JAK/STAT, leading to sustained inflammation and extracellular matrix (ECM) breakdown. Recent studies have identified pharmacological and gene-based approaches that modulate SASP-related pathways. Small molecules such as anakinra, metformin, and rapamycin(definition) show potential in reducing inflammation and preserving cartilage, while microRNA modulation and CRISPR/Cas9 editing provide emerging means to regulate SASP factors at the transcriptional level. This review summarizes the molecular mechanisms by which the SASP contributes to OA pathogenesis and highlights novel therapeutic strategies aimed at attenuating inflammation, maintaining cartilage integrity, and mitigating disease progression.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fimmu.2026.1850495
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Chan, M., Low, P., Ong, S.C., Choy, S.M., Lee, W.X., Goh, K.Y., Ng, K., Chua, K., Lee, J.Y., Guo, A.K., Jia, J., Tan, E.K., Tang, H., & Chua, K. (2026). Inflammaging and osteoarthritis - therapeutic opportunities. <em>Frontiers in Immunology</em>. https://doi.org/10.3389/fimmu.2026.1850495
Vancouver
Chan M, Low P, Ong SC, Choy SM, Lee WX, Goh KY, et al. Inflammaging and osteoarthritis - therapeutic opportunities. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.1850495.
BibTeX
@article{megan2026Inflam,
title = {Inflammaging and osteoarthritis - therapeutic opportunities},
author = {Megan Chan and Phoebe Low and Shi Chee Ong and Sze Mun Choy and Wen Xing Lee and Kah Yong Goh and Kym Ng and Kimberly Chua and Jia Ying Lee and Alvin Kunyao Guo and Jiang Jia and Eng King Tan and Hong-Wen Tang and Kenon Chua},
journal = {Frontiers in Immunology},
year = {2026},
doi = {10.3389/fimmu.2026.1850495},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Pharmacology 2025
Open access · CC-BY
Recent advances in dermal fibroblast senescence and skin aging: unraveling mechanisms and pioneering therapeutic strategies
Biomolecules 2025
Open access · CC-BY
Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions
Immunological Reviews 2026
Open access · CC-BY
Cellular Senescence, Inflammaging and Cardiovascular Disease
Immunological investigations 2026
Citation only
Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies.
Immunological Investigations 2026
Citation only
Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies
Drug design, development and therapy 2025
Open access · OA